2 results
Approved WMOPending
To assess long-term safety and tolerability of bosentan in patients with IPF.
Approved WMOCompleted
· To determine therapeutic efficacy of Tracleer in patients with active Behcet disease. Furthermore:· To study cytokine and immunological patterns and ET-1levels in those patients.